Home  >  Products  >  PSCA (prostate stem cell antigen) Blocking Peptide (the C terminal of PSCA)(100ug)
PSCA (prostate stem cell antigen) Blocking Peptide (the C terminal of PSCA)(100ug)

PSCA (prostate stem cell antigen) Blocking Peptide (the C terminal of PSCA)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-PSCA Antibody(ARP42250_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP42250
Size: 100ug
Weight: 8kDa
Gene: 8000
Format: Lyophilized powder
Target: This gene encodes a glycosylphosphatidylinositol-anchored cell membrane glycoprotein. In addition to being highly expressed in the prostate it is also expressed in the bladder, placenta, colon, kidney, and stomach. This gene is up-regulated in a large proportion of prostate cancers and is also detected in cancers of the bladder and pancreas. This gene includes a polymorphism that results in an upstream start codon in some individuals; this polymorphism is thought to be associated with a risk for certain gastric and bladder cancers. Alternative splicing results in multiple transcript variants.
Alternative names: PRO232
See Full Product Listings >